This immigrant just became a biotech billionaire
Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, have been on fire. Now both of its co-CEOs are billionaires.
Shares of Summit Therapeutics, whose cancer drug candidate turned heads after it outperformed a blockbuster drug from Merck, have been on fire. Now both of its co-CEOs are billionaires.
One analyst said the “highly anticipated leadership change will inject a much-needed sense of urgency” to Nike, whose share price remains down 50% from its 2021 peak.
Cards Against Humanity has a long history of trolling Donald Trump and Elon Musk.
While generative AI is still a relatively new technology, 2024 is emerging as a defining year as users explore powerful ways to apply it in their workday.
Bryan deactivated his X account and posted a series of Instagram stories apologizing to both Swift and her fans.
A rally from the “magnificent seven” tech stocks perhaps predictably fueled the rally, but this surprise name was the S&P 500’s biggest gainer Thursday.
How do high performers like Sara Blakely and Melanie Perkins juggle it all? With 70% of women taking on primary caregiving roles, their secret lies in an invisible army of support staff that turns time into their greatest asset, writes Cherie Clonan.
A small asteroid, named 2024 PT5, will orbit Earth as a second moon from September 29 to November 25, 2024.
The Tesla CEO wrote in a since-deleted post that “no one is even trying to assassinate” Biden or Harris.
LinkedIn doesn’t get explicit consent for training AI, requiring users to opt out.